ProShare Advisors
PAHC icon

ProShare Advisors’s Phibro Animal Health PAHC Stock Holding History

ProShare Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,106
Closed -$227K – 1991
2026
Q1 		$227K Buy
+4,106
New +$195K ﹤0.01% 1498
2021
Q3 		– Sell
-9,511
Closed -$275K – 2189
2021
Q2 		$275K Buy
9,511
+652
+7% +$17.6K ﹤0.01% 1952
2021
Q1 		$216K Buy
+8,859
New +$200K ﹤0.01% 1994

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ProShare Advisors's PAHC Position: Q2 2026 in Review

ProShare Advisors sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 4,106 shares — an estimated $227K sold.

ProShare Advisors first reported a position in PAHC in Q1 2021 and held it in 3 quarters. The position peaked at $275K in Q2 2021. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • ProShare Advisors reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • ProShare Advisors sold 4,106 Phibro Animal Health shares in Q2 2026, an estimated $227K.
  • ProShare Advisors first reported a position in Phibro Animal Health in Q1 2021 and held it in 3 quarters.
  • ProShare Advisors's Phibro Animal Health position peaked at $275K in Q2 2021.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.